Background and aims: Nonalcoholic fatty liver disease (NAFLD) is a complex disease, resulting from the interplay between environmental determinants and genetic variations. Single nucleotide polymorphism rs738409 C>G in the PNPLA3 gene is associated with hepatic fibrosis and with higher risk of developing hepatocellular carcinoma. Here, we analyzed a longitudinal cohort of biopsy-proven NAFLD subjects with the aim to identify individuals in whom genetics may have a stronger impact on disease progression. Methods: We retrospectively analyzed 756 consecutive, prospectively enrolled biopsy-proven NAFLD subjects from Italy, United Kingdom, and Spain who were followed for a median of 84 months (interquartile range, 65-109 months). We stratified the study cohort according to sex, body mass index (BMI)

Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients with Nonalcoholic Fatty Liver Disease / C. Rosso, G.P. Caviglia, G. Birolo, A. Armandi, G. Pennisi, S. Pelusi, R. Younes, A. Liguori, N. Perez-Diaz-Del-Campo, A. Nicolosi, O. Govaere, G. Castelnuovo, A. Olivero, M.L. Abate, D.G. Ribaldone, P. Fariselli, L. Valenti, L. Miele, S. Petta, M. Romero-Gomez, Q.M. Anstee, E. Bugianesi. - In: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. - ISSN 1542-3565. - (2023), pp. 1-11. [Epub ahead of print] [10.1016/j.cgh.2023.04.024]

Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients with Nonalcoholic Fatty Liver Disease

S. Pelusi;L. Valenti;
2023

Abstract

Background and aims: Nonalcoholic fatty liver disease (NAFLD) is a complex disease, resulting from the interplay between environmental determinants and genetic variations. Single nucleotide polymorphism rs738409 C>G in the PNPLA3 gene is associated with hepatic fibrosis and with higher risk of developing hepatocellular carcinoma. Here, we analyzed a longitudinal cohort of biopsy-proven NAFLD subjects with the aim to identify individuals in whom genetics may have a stronger impact on disease progression. Methods: We retrospectively analyzed 756 consecutive, prospectively enrolled biopsy-proven NAFLD subjects from Italy, United Kingdom, and Spain who were followed for a median of 84 months (interquartile range, 65-109 months). We stratified the study cohort according to sex, body mass index (BMI)
Liver-Related Outcomes; NAFLD; NASH; PNPLA3;
Settore MED/09 - Medicina Interna
2023
4-mag-2023
https://www.cghjournal.org/article/S1542-3565(23)00324-5/fulltext
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1542356523003245-main.pdf

embargo fino al 04/05/2024

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 1.61 MB
Formato Adobe PDF
1.61 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/975449
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact